Menu Close

Trending

Data backs AZ’s Wilson disease drug, but with a question mark
Fujifilm acquires AI tech to improve fertility treatment
Sarepta shares yo-yo as FDA places hold on Duchenne trial
New countries stockpile antiviral TPOXX as monkeypox outbreak continues
Biogen and Happify partner on digital support for MS patients

Akebia Therapeutics

blood_cells1 1024x576

Market Access/ News/ News

GSK goes for gold as FDA starts review of daprodustat

, , , , , , , , 0 Comment

GlaxoSmithKline says the FDA has started its review of daprodustat for anaemia associated with chronic kidney disease (CKD),

X
GSK goes for gold as FDA starts review of daprodustat
https://pharmaphorum.com/news/fda-starts-review-of-gsks-kidney-drug-daprodustat/
Ardelyx’s-ambition-to-revolutionise-kidney-treatment

Market Access/ News/ News

After FDA snub, EMA backs FibroGen, Astellas’ roxadustat

, , , , , , , , , , , 0 Comment

The EU regulator has approved FibroGen and Astellas Evrenzo for adults with anaemia caused by chronic kidney disease

X
After FDA snub, EMA backs FibroGen, Astellas’ roxadustat
https://pharmaphorum.com/news/after-fda-snub-ema-backs-fibrogen-astellas-roxadustat/

Login

CONTINUE TO SITE >
X
Close in 10 seconds